Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hospira Unveils New Quality Laboratory

Published: Thursday, October 31, 2013
Last Updated: Thursday, October 31, 2013
Bookmark and Share
New quality laboratory and technological advances improve manufacturing flow and enhance ability to supply customers with life-impacting drugs.

Hospira, Inc. has unveiled a new quality and analytical testing laboratory at its Rocky Mount, N.C., plant in a ribbon-cutting ceremony attended by North Carolina Governor Pat McCrory and other local and state government leaders.

The ceremony highlighted the importance of the quality laboratory, and all of the capital improvements at the plant, to Hospira, the local community and patients around the globe.

"Rocky Mount's new laboratory, coupled with our investments throughout the plant, will help ensure that we continue to supply high-quality, more affordable medicines to customers and patients who need them," said Marty Nealey, vice president, Rocky Mount Operations, Hospira.

Nealey continued, "Through advanced technology and additional space, we've been able to gradually increase our production levels and ensure more consistent release of products, ultimately supporting our ability to provide a more sustainable supply of many life-impacting drugs. I'm very proud of all of the team members here at Rocky Mount and very thankful for the support of this community and our state in furthering our commitment to advancing wellness."

Part of Hospira's more than $200 million investment at Rocky Mount, which includes significant capital investments, this new, quality laboratory will be home to 200 employees, responsible for evaluating and testing more than 450 different products.

The laboratory features the latest technology and advancements in quality and analytical testing and inspection.

The construction of the quality laboratory was made possible, in part, by local and state incentives, including a grant from the One North Carolina Fund, which provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs in the state. Since the grant was awarded, Hospira has added nearly 200 jobs to the Rocky Mount plant overall.

"Creating jobs in North Carolina is one of my top priorities and I would like to thank Hospira for its investment in Rocky Mount and North Carolina," said Governor Pat McCrory. "We have a very strong and talented workforce that will provide Hospira with skilled workers that they are looking for. We look forward to a great relationship and watching the company grow here in North Carolina."

The opening of the quality lab and other improvements at the Rocky Mount plant are part of a broad effort by Hospira to ensure consistent access to its more affordable, high-quality drugs.

"For nearly 80 years, Hospira has been an integral part of the healthcare system, serving hundreds of millions of patients with affordable drugs and delivery systems worldwide," said F. Michael Ball, chief executive officer, Hospira, at today's ceremony.

Ball continued, "We are investing more than $1 billion globally to not only serve the patients and hospitals that depend on us with high-quality products in sustainable supply today, but also to make sure that our central role in this system remains vibrant in the future."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pfizer Completes Acquisition of Hospira
Expected to be immediately accretive to adjusted diluted EPS1 upon closing.
Friday, September 11, 2015
Scientific News
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!